Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Beck

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Pediatric Urology|August 27, 2010
Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentationRahul Mehan, Rosalia Misseri, Brian Vanderbrink, et al.
The Journal of Urology|September 8, 2005
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Urologic Oncology|September 9, 2010
Serum tumor markers in testicular cancerYaron Ehrlich, Stephen D W Beck, Richard S Foster, et al.
The Journal of Urology|February 14, 2007
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?Stephen D W Beck, Liang Cheng, Richard Bihrle, et al.
AJNR. American Journal of Neuroradiology|September 1, 1986
Intradural spinal teratoma: case report and review of the literatureW R Smoker, J Biller, S A Moore, et al.
Journal of Neurochemistry|October 1, 1983
Uptake of adenosine by cultured cerebral vascular smooth muscle cellsD W Beck, H V Vinters, S A Moore, et al.
The Journal of Urology|June 15, 2007
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patientsStephen D W Beck, Matthew D Peterson, Richard Bihrle, et al.
The Urologic Clinics of North America|May 9, 2007
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcomeStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|April 18, 2009
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgeryStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissectionStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Pediatric Urology|August 27, 2010
Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentationRahul Mehan, Rosalia Misseri, Brian Vanderbrink, et al.
The Journal of Urology|September 8, 2005
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Urologic Oncology|September 9, 2010
Serum tumor markers in testicular cancerYaron Ehrlich, Stephen D W Beck, Richard S Foster, et al.
The Journal of Urology|February 14, 2007
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?Stephen D W Beck, Liang Cheng, Richard Bihrle, et al.
AJNR. American Journal of Neuroradiology|September 1, 1986
Intradural spinal teratoma: case report and review of the literatureW R Smoker, J Biller, S A Moore, et al.
Journal of Neurochemistry|October 1, 1983
Uptake of adenosine by cultured cerebral vascular smooth muscle cellsD W Beck, H V Vinters, S A Moore, et al.
The Journal of Urology|June 15, 2007
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patientsStephen D W Beck, Matthew D Peterson, Richard Bihrle, et al.
The Urologic Clinics of North America|May 9, 2007
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcomeStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|April 18, 2009
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgeryStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissectionStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Pageof 9